BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:13 PM
 | 
May 18, 2009
 |  BC Extra  |  Company News

Biovail acquiring tetrabenazine portfolio

Biovail Corp. (TSX:BVF; NYSE:BVF) will acquire worldwide rights to a portfolio of tetrabenazine products from Cambridge Laboratories Ltd. (Dublin, Ireland) for $200 million up front, plus $30 million in two tranches over...

Read the full 148 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >